LncRNA ZEB1-AS1 Promotes Migration and Metastasis of Bladder Cancer Cells by Post-transcriptional Activation of ZEB1

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2019 May 23

PMID 31115480

Citations 24

Authors

Xin Zhao

Dongwen Wang

Yongxue Ding

Jingmin Zhou

Guanghua Liu

Zhigang Ji

Affiliations

Soon will be listed here.

Abstract

The prognosis for patients with metastatic bladder cancer (BCa) is poor, and has not been improved by current treatment methods. Long noncoding RNAs (lncRNAs) are involved in the pathology of various tumors, including bladder cancer. However, the role of zinc finger E‑box‑binding homeobox 1‑antisense 1 (ZEB1‑AS1) in BCa progression and metastasis remains unclear. The present study determined the expression level of ZEB1‑AS1 in BCa and additionally investigated the functional role of ZEB1‑AS1 in BCa metastasis. Reverse transcription quantitative polymerase chain reaction analysis showed that ZEB1‑AS1 was upregulated in BCa cells compared with normal epithelial cells. Functionally, knockdown of ZEB1‑AS1 suppressed BCa cell migration and invasion in vitro, and metastasis in vivo. Mechanistic investigations revealed that ZEB1‑AS1 bound to heterogenous nuclear ribonucleoprotein D0 (AUF1), thereby activating the translation of ZEB1 mRNA without affecting its mRNA level. In addition, ZEB1‑AS1 was significantly upregulated in BCa tissues and muscle‑invasive BCa cases. ROC curve analysis demonstrated that ZEB1‑AS1 expression was associated with metastasis in patients with BCa. In conclusion, the data from the present study demonstrated that ZEB1‑AS1 induced BCa metastasis via an AUF1‑mediated translation activation of ZEB1 mRNA mechanism. ZEB1‑AS1 may serve as a promising target for clinical intervention in advanced BCa.

Citing Articles

LncRNA ZEB1-AS1 promotes the proliferation and migration of non-small cell lung cancer by activating epithelial-mesenchymal transition with STAT3.

Chen Z, Yao Y, Gao J Transl Cancer Res. 2025; 14(1):584-594.

PMID: 39974382 PMC: 11833408. DOI: 10.21037/tcr-2024-2276.

JAM3: A prognostic biomarker for bladder cancer via epithelial-mesenchymal transition regulation.

Pang Z, Wang J, Wang J, Wang Y, Ji B, Xu Y Biomol Biomed. 2024; 24(4):897-911.

PMID: 38400838 PMC: 11293228. DOI: 10.17305/bb.2024.9979.

Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer.

Chin F, Chan S, Veerakumarasivam A Diagnostics (Basel). 2023; 13(16).

PMID: 37627900 PMC: 10453580. DOI: 10.3390/diagnostics13162641.

The Roles of Antisense Long Noncoding RNAs in Tumorigenesis and Development through Cis-Regulation of Neighbouring Genes.

Jiang B, Yuan Y, Yi T, Dang W Biomolecules. 2023; 13(4).

PMID: 37189431 PMC: 10135817. DOI: 10.3390/biom13040684.

Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer.

Verhoeff T, Holloway A, Dickinson J Cell Oncol (Dordr). 2022; 46(2):239-250.

PMID: 36512308 PMC: 10060301. DOI: 10.1007/s13402-022-00752-y.

References

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Minn A, Gupta G, Siegel P, Bos P, Shu W, Giri D . Genes that mediate breast cancer metastasis to lung. Nature. 2005; 436(7050):518-24. PMC: 1283098. DOI: 10.1038/nature03799. View

Cao Y . Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer. 2005; 5(9):735-43. DOI: 10.1038/nrc1693. View

Wu X . Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer. 2005; 5(9):713-25. DOI: 10.1038/nrc1697. View

Gupta R, Shah N, Wang K, Kim J, Horlings H, Wong D . Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464(7291):1071-6. PMC: 3049919. DOI: 10.1038/nature08975. View

Youssef R, Raj G . Lymphadenectomy in management of invasive bladder cancer. Int J Surg Oncol. 2012; 2011:758189. PMC: 3263693. DOI: 10.1155/2011/758189. View

Hautmann R, de Petriconi R, Pfeiffer C, Volkmer B . Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012; 61(5):1039-47. DOI: 10.1016/j.eururo.2012.02.028. View

Kornienko A, Guenzl P, Barlow D, Pauler F . Gene regulation by the act of long non-coding RNA transcription. BMC Biol. 2013; 11:59. PMC: 3668284. DOI: 10.1186/1741-7007-11-59. View

Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

10.

Nakagawa S, Kageyama Y . Nuclear lncRNAs as epigenetic regulators-beyond skepticism. Biochim Biophys Acta. 2013; 1839(3):215-22. DOI: 10.1016/j.bbagrm.2013.10.009. View

11.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2013; 15(1):7-21. DOI: 10.1038/nrg3606. View

12.

Karaman S, Detmar M . Mechanisms of lymphatic metastasis. J Clin Invest. 2014; 124(3):922-8. PMC: 3938272. DOI: 10.1172/JCI71606. View

13.

Moore A, Chenette D, Larkin L, Schneider R . Physiological networks and disease functions of RNA-binding protein AUF1. Wiley Interdiscip Rev RNA. 2014; 5(4):549-64. DOI: 10.1002/wrna.1230. View

14.

Van Batavia J, Yamany T, Molotkov A, Dan H, Mansukhani M, Batourina E . Bladder cancers arise from distinct urothelial sub-populations. Nat Cell Biol. 2014; 16(10):982-91, 1-5. DOI: 10.1038/ncb3038. View

15.

Loewen G, Jayawickramarajah J, Zhuo Y, Shan B . Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014; 7:90. PMC: 4266198. DOI: 10.1186/s13045-014-0090-4. View

16.

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

17.

Choi Y, Yoon J, Chang J . Crystal Structure of the N-Terminal RNA Recognition Motif of mRNA Decay Regulator AUF1. Biomed Res Int. 2016; 2016:3286191. PMC: 4942602. DOI: 10.1155/2016/3286191. View

18.

Lv Q, Hu L, Chen S, Sun B, Fu M, Qin C . A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma. Int J Mol Sci. 2016; 17(9). PMC: 5037710. DOI: 10.3390/ijms17091431. View

19.

Li S, Zhang H, Du Z, Li C, An M, Zong Z . Induction of epithelial-mesenchymal transition (EMT) by Beclin 1 knockdown via posttranscriptional upregulation of ZEB1 in thyroid cancer cells. Oncotarget. 2016; 7(43):70364-70377. PMC: 5342558. DOI: 10.18632/oncotarget.12217. View

20.

Liu C, Lin J . Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1. Am J Transl Res. 2016; 8(10):4095-4105. PMC: 5095304. View